142121-94-6 Usage
General Description
N-Boc-DL-3-FluoroPhenylglycine is a chemical compound that falls under the category of amino acids and peptides. It is specifically a derivative of phenylglycine, which is a non-proteinogenic amino acid. The "N-Boc" in its name refers to the protection of the amino group with a tert-butoxycarbonyl (Boc) group, which is commonly used in peptide synthesis to prevent unwanted reactions. The addition of a 3-fluoro group to the phenyl ring also adds unique properties to the compound, potentially influencing its biological activity and interactions within a biological system. The compound may have applications in pharmaceutical research and drug development, particularly in the field of peptide-based therapeutics.
Check Digit Verification of cas no
The CAS Registry Mumber 142121-94-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,1,2 and 1 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 142121-94:
(8*1)+(7*4)+(6*2)+(5*1)+(4*2)+(3*1)+(2*9)+(1*4)=86
86 % 10 = 6
So 142121-94-6 is a valid CAS Registry Number.
142121-94-6Relevant articles and documents
HETEROARYL DERIVATIVES
-
Paragraph 0502; 0503; 0504; 0505, (2015/06/17)
Compounds of formula (I) described herein are both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists and are useful for the prevention and/or treatment of diseases of the respiratory tract characterized by airway obstruction.
PHENYLETHYLPYRIDINE DERIVATIVES AS PDE4-INHIBITORS
-
Page/Page column 69; 70, (2014/06/24)
The invention relates to novel compounds which are both inhibitors of the phosphodiesterase 4 (PDE4) enzyme and muscarinic M3 receptor antagonists, methods of preparing such compounds, compositions containing them and therapeutic use thereof.
GLYCINE DERIVATIVES AND THEIR USE AS MUSCARINIC RECEPTOR ANTAGONISTS
-
Page/Page column 64-65, (2012/06/15)
The present invention relates to alkaloid aminoester derivatives acting as muscarinic receptor antagonists, processes for their preparation, compositions comprising them and therapeutic uses thereof.
